Management of Cardiogenic Shock

  • Robert A. Montgomery
  • Robb Kociol
Part of the Clinical Cases in Cardiology book series (CCC)


A 52 year old man with no known past medical history presents to the emergency department with 24 hours of chest pain, nausea and vomiting. An initial EKG shows a right bundle branch block (RBBB) and ST elevations in anterolateral leads (Fig. 9.1). He is given intravenous heparin, prasugrel and aspirin and taken directly to the cardiac catheterization lab. Coronary angiography reveals chronic appearing 100% right coronary artery (RCA) occlusion with left to right collateralization and 100% left anterior descending (LAD) artery occlusion. Two drug-eluting stents are placed into the LAD with restoration of TIMI 3 flow (see Table 9.1 for definition). Left ventriculogram reveals diffuse hypokinesis and a left ventricular end-diastolic pressure (LVEDP) of 30–35 mmHg. The patient is confused and not following commands. An intra-aortic balloon pump is placed. Arrangements are then made to transfer to tertiary care center for further management.


Myocardial infarction Shock Cardiogenic 


  1. 1.
    Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76(1):142–54.CrossRefPubMedGoogle Scholar
  2. 2.
    Koerselman J. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation. 2003;107(19):2507–11.CrossRefPubMedGoogle Scholar
  3. 3.
    Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest. 2004;125(2):669–82.CrossRefPubMedGoogle Scholar
  4. 4.
    Nable JV, Brady W. The evolution of electrocardiographic changes in ST-segment elevation myocardial infarction. Am J Emerg Med. 2009;27(6):734–46.CrossRefPubMedGoogle Scholar
  5. 5.
    Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. SHOCK registry investigators. Circulation. 1995;91(3):873–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116(7):e148–304.CrossRefPubMedGoogle Scholar
  7. 7.
    Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001;134(6):451–8. Available from: and Scholar
  8. 8.
    O’Gara PT, Kushner FG, Ascheim DD, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2013;61(4):e78–e140. Available from: and Scholar
  9. 9.
    Perera D, Lumley M, Pijls N, Patel MR. Intra-aortic balloon pump trials: questions, answers, and unresolved issues. Circ Cardiovasc Interv. 2013;6(3):317–21.CrossRefPubMedGoogle Scholar
  10. 10.
    van Nunen LX, Noc M, Kapur NK, Patel MR, Perera D, Pijls NH. Usefulness of intra-aortic balloon pump counterpulsation. Am J Cardiol. 2016;117(3):469–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Briceno N, Kapur NK, Perera D. Percutaneous mechanical circulatory support: current concepts and future directions. Heart. 2016;102(18):1494–507.CrossRefPubMedGoogle Scholar
  12. 12.
    Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock. JAMA. 2011;306(12):1329–37.CrossRefPubMedGoogle Scholar
  13. 13.
    Kohsaka S, Menon V, Lowe AM. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165:1643.CrossRefPubMedGoogle Scholar
  14. 14.
    Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28(8):827–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie D’intervention). J Card Fail. 2015;21:499.CrossRefPubMedGoogle Scholar
  16. 16.
    Gibson TC. The significance of fever in acute myocardial infarction: a reappraisal. Am Heart J. 1974;87(4):439–44.CrossRefPubMedGoogle Scholar
  17. 17.
    Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122(2):173–83.CrossRefPubMedGoogle Scholar
  18. 18.
    Peura JL, Colvin-Adams M, Francis GS, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126(22):2648–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Kar B, Adkins LE, Civitello AB, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006;33(2):111–5. Available from: Scholar
  20. 20.
    Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I. Circulation. 2008;117(11):1436–48.CrossRefPubMedGoogle Scholar
  21. 21.
    Morine KJ, Kiernan MS, Pham DT, Paruchuri V, Denofrio D, Kapur NK. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. J Card Fail. 2016;22(2):110–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Windecker S, Kolh P, Alfonso F, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2014;35(37):2541–619.CrossRefPubMedGoogle Scholar
  23. 23.
    Kantrowitz A. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on management of acute myocardial infarction). Circulation. 1999;100(9):1016–30.CrossRefPubMedGoogle Scholar
  25. 25.
    Thiele H, Zeymer U, Neumann F-J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–96.CrossRefPubMedGoogle Scholar
  26. 26.
    Funk M, Gleason J, Foell D. Lower limb ischemia related to use of the intraaortic balloon pump. Heart Lung. 1989;18(6):542–52.PubMedGoogle Scholar
  27. 27.
    Freed PS, Wasfie T, Zado B, Kantrowitz A. Intraaortic balloon pumping for prolonged circulatory support. Am J Cardiol. 1988;61(8):554–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Rossiter-Thornton M, Arun V, Forrest AP, Bayfield MS, Wilson MK. Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery. Heart Lung Circ. 2008;17(3):243–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276–83.CrossRefPubMedGoogle Scholar
  31. 31.
    Abiomed. Available from:
  32. 32.
    Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917–22.CrossRefPubMedGoogle Scholar
  33. 33.
    Burkhoff D, Cohen H, Brunckhorst C, O’Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.e1–8. Available from: and Scholar
  34. 34.
    John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141(4):932–9. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Beth Israel Deaconess Medical CenterBostonUSA

Personalised recommendations